Bladder Melanoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery (NCT05111574) | National Cancer Institute (NCI) | 2022-08-11 |
Track Bladder Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.